Neurosteer

Neurosteer, Inc. has developed the world's first wearable, medical-grade brain activity interpretation platform for a wide range of medical, health, and lifestyle applications, enabling early detection and more effective treatment of various neurological disorders. The platform consists of a medical-grade wearable device and a cloud-based system that provides real-time monitoring and assessment of brain activity. The company is currently focused on providing objective biomarkers to identify the early onset of Parkinson’s disease, Alzheimer’s disease, dementia, and epilepsy.